Psychomotor Agitation: all 231 studies

Page 1 of 3. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.

• Virtual Reality to Advance Dementia Care and Quality of LifeNot yet recruitingNCT07893678Not applicable
• Protocolized Receptive Music Intervention to Reduce Care Refusal in Nursing Home Residents With Major Neurocognitive DisordersRecruitingNCT07730957Not applicable
• PARO-agitation-studyRecruitingNCT07568093Not applicable
• Effect of Daily Screen Time on Postoperative Emergence Delirium in Children Aged 2-11 YearsRecruitingNCT07552896
• Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled TrialNot yet recruitingNCT07377981Phase 4
• Melatonin for Post Tonsillectomy Emergence Agitation in PediatricRecruitingNCT07375342Not applicable
• The Effect of Therapeutic Touch on Agitation, Pain, and Cortisol Levels in Intensive Care PatientsNot yet recruitingNCT07061340Not applicable
• Responsive Nature-Driven Imagery to Reduce Delirium After Cardiac SurgeryNot yet recruitingNCT07051096Not applicable
• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's DiseaseRecruitingNCT07011745Phase 3
• Comparison of Haloperidol and Dexmedetomidine for Delirium and Agitation in ICU Patients With Traumatic Brain InjuryNot yet recruitingNCT06993194Not applicable
• A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)RecruitingNCT06937229Phase 3
• Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseaseRecruitingNCT06808984Phase 2
• Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.RecruitingNCT06781333Phase 2
• Acute Agitation in Emergency PsychiatryRecruitingNCT06752616Phase 2/3
• Neurosteer Bedside Monitoring SystemRecruitingNCT06718764Not applicable
• Effects of Dexmedetomidine on Agitation in Critically Ill TBI PatientsNot yet recruitingNCT06620393Phase 2/3
• Clinical Trial of Peer Support in the ED (PCORI)Not yet recruitingNCT06556069Not applicable
• the Multi-modal Evaluation of Agitation in Critically Ill Patients Based on Remote Video-Ultra-sensitive Detection WaveRecruitingNCT06543602
• Evaluation of The Relationship Between Perioperative Hypothermia and Emergence AgitationRecruitingNCT06543134
• A Music-Based Mobile App for People Living With Alzheimer's Disease and Related Dementias (ADRD)RecruitingNCT06140342
• Individualized Music Playlist Based on ISO Principle for De-escalation of Agitation in DementiaNot yet recruitingNCT06104436Not applicable
• Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar DisorderRecruitingNCT06093451Phase 4
• Premature Enhanced Automated Capture of Comfort KnowledgeRecruitingNCT06037629
• A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint UseRecruitingNCT05783505Not applicable
• Safe Brain Initiative, Operationalizing Precision AnaesthesiaRecruitingNCT05765162
• Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients.RecruitingNCT05522647
• Nabilone for Agitation Blinded Intervention TrialRecruitingNCT04516057Phase 3
• Delirium, Agitation/Sedation, Pain and Dyspnea in Respiratory Intensive Care Unit (NIVILIUM)RecruitingNCT03880084
• An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension StudyTerminatedNCT06736509Phase 3Results posted
• Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar DisorderCompletedNCT06041646Phase 4Results posted
• Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)TerminatedNCT05665088Phase 3Results posted
• A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease AgitationCompletedNCT05557409Phase 3Results posted
• An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With DementiaTerminatedNCT05276830Phase 2Results posted
• Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)CompletedNCT05271552Phase 3Results posted
• Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeTerminatedNCT04464564Phase 3Results posted
• Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeTerminatedNCT04408755Phase 3Results posted
• Dexmedetomidine in the Treatment of Agitation Associated With Bipolar DisorderCompletedNCT04276883Phase 3Results posted
• Dexmedetomidine in the Treatment of Agitation Associated With SchizophreniaCompletedNCT04268303Phase 3Results posted
• Sub-Lingual Dexmedetomidine in Agitation Associated With DementiaCompletedNCT04251910Phase 1/2Results posted
• Prazosin for Agitation in Alzheimer's DiseaseCompletedNCT03710642Phase 2Results posted
• TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency SettingCompletedNCT03639558Phase 4Results posted
• A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's TypeCompletedNCT03594123Phase 3Results posted
• A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's TypeCompletedNCT03548584Phase 3Results posted
• Effects of Dexmedetomidine on Delirium Duration of Non-intubated ICU Patients (4D Trial)CompletedNCT03317067Phase 3Results posted
• Addressing Dementia Via Agitation-Centered EvaluationCompletedNCT03226522Phase 2/3Results posted
• A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's DiseaseCompletedNCT03118947Phase 2Results posted
• Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for AgitationTerminatedNCT03110900Phase 4Results posted
• Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain InjuryCompletedNCT03095066Phase 2Results posted
• A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and AggressionTerminatedNCT03044249Phase 2Results posted
• Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)TerminatedNCT02992132Phase 2Results posted
• Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients.TerminatedNCT02846740Not applicableResults posted
• Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's DiseaseCompletedNCT02792257Phase 2Results posted
• Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeCompletedNCT02442765Phase 3Results posted
• Does Intraoperative Clonidine Reduce Post Operative Agitation in Children?CompletedNCT02361476Phase 4Results posted
• Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence AgitationCompletedNCT02256358Not applicableResults posted
• Study of Sedative Medications in Patients With Severe Infection and Respiratory FailureCompletedNCT02203019Phase 4Results posted
• Treatment of Psychosis and Agitation in Alzheimer's DiseaseCompletedNCT02129348Phase 2Results posted
• Cartoon Distraction and Parental Presence on Anxiety in Pediatric AnesthesiaCompletedNCT02027844Not applicableResults posted
• Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's TypeCompletedNCT01922258Phase 3Results posted
• Dexmedetomidine to Prevent Agitation After Free Flap SurgeryCompletedNCT01904760Phase 4Results posted
• A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's AgitationCompletedNCT01862640Phase 3Results posted
• Acupuncture to Improve Comfort of Children on a Ventilator in the Intensive Care UnitCompletedNCT01848158Not applicableResults posted
• A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseaseTerminatedNCT01766336Phase 2Results posted
• Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseaseCompletedNCT01735630Phase 2Results posted
• Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's DiseaseCompletedNCT01584440Phase 2Results posted
• Treating Acutely Agitated Patients With Asenapine Sublingual TabletsCompletedNCT01400113Phase 4Results posted
• Nicotine Replacement Therapy in the Intensive Care UnitCompletedNCT01362959Phase 4Results posted
• Citalopram for Agitation in Alzheimer's DiseaseCompletedNCT00898807Phase 3Results posted
• Use of Dexmedetomidine to Reduce Emergence Delirium Incident in ChildrenCompletedNCT00857727Phase 3Results posted
• Treatment for Aggression and Agitation in Patients With Alzheimer's DiseaseCompletedNCT00843518Phase 2Results posted
• Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in SchizophreniaCompletedNCT00797277Phase 3Results posted
• A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With AgitationCompletedNCT00723606Phase 3Results posted
• Actigraphic Analysis of Treatment ResponseCompletedNCT00723580Not applicableResults posted
• Staccato Loxapine in Agitated Patients With Bipolar DisorderCompletedNCT00721955Phase 3Results posted
• Staccato Loxapine in Agitated Patients With SchizophreniaCompletedNCT00628589Phase 3Results posted
• A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency RoomCompletedNCT00457366Phase 4Results posted
• Antipsychotic Discontinuation in Alzheimer's DiseaseCompletedNCT00417482Phase 4Results posted
• Staccato Loxapine in Agitation (Proof of Concept)CompletedNCT00369577Phase 2Results posted
• Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) DeliriumCompletedNCT00351299Phase 2Results posted
• Alzheimer's in Long-Term Care--Treatment for AgitationCompletedNCT00161473Not applicableResults posted
• Weighted Blankets for Agitation in Adults in the Intensive Care UnitActive, not recruitingNCT07920497Not applicable
• Family Videos and Virtual Reality in Intensive Care PatientsCompletedNCT07794696Not applicable
• Effect of Virtual Reality on Agitation in Acute StrokeCompletedNCT07787910Not applicable
• Impact of Harp Therapy on Behavioral Disorders in Nursing Home Residents With Neurodegenerative Disease (ARPE)CompletedNCT07748013
• Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill PatientsCompletedNCT07649876Not applicable
• Acupressure for Agitation, Pain, and Sleep in Mechanically Ventilated ICU PatientsCompletedNCT07619326Not applicable
• Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar DisorderCompletedNCT07116694Phase 2
• The Effect of Preoperative Counseling on Emergence Agitation in Patients Candidate for Nasal SurgeriesCompletedNCT06686511
• Doll Therapy for Agitated Elderly Dementia PeopleCompletedNCT06578819Not applicable
• A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia.TerminatedNCT06217146Not applicable
• Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's TypeActive, not recruitingNCT06052254Phase 2
• Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency DepartmentWithdrawnNCT05974527Phase 4
• Nabilone for Agitation in Frontotemporal DementiaTerminatedNCT05742698Phase 2
• Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)CompletedNCT05658510Phase 3
• Life's End Benefits of cannaBidiol and tetrahYdrocannabinolCompletedNCT05644262Phase 2
• Post Anesthesia Care Unit (PACU) Weighted Blanket StudyCompletedNCT05632640Not applicable
• Dronabinol for Agitation in Dementia Crossover TrialWithdrawnNCT05612711Phase 2
• Clinical Trial on Agitation in Alzheimer's DementiaActive, not recruitingNCT05543681Phase 2
• Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's TypeActive, not recruitingNCT05397639Phase 3
• Effects of Perioperative TEAS on Postoperative Pain and Agitation in Pediatric Adenoidectomy and TonsillectomyStatus unknownNCT05330494Not applicable

← Psychomotor Agitation overview